Position in CERS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$613,600
+$317,871 QoQ
Shares Held
210,137
+15.1% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 186 holders
Holding Since
Jun 2023
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CERS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $576,060,759 across 26 Medical Devices names. CERS ranks #21 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
2,772,232 | $250,776,106 | |
| 2 | GEHC |
GE HealthCare Technologies Inc.
|
1,862,023 | $119,188,092 | |
| 3 | TXG |
10x Genomics, Inc.
|
2,019,883 | $77,442,314 | |
| 4 | TNDM |
Tandem Diabetes Care Inc
|
2,006,429 | $30,277,013 | |
| 5 | ATEC |
Alphatec Holdings, Inc.
|
3,352,133 | $28,995,950 | |
| 6 | AXGN |
Axogen, Inc.
|
386,423 | $17,848,878 | |
| 7 | NVCR |
NovoCure Ltd
|
1,164,072 | $17,635,690 | |
| 8 | VREX |
Varex Imaging Corp
|
479,785 | $5,004,157 |
All Filings in CERS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $613,600 | 210,137 | Shares | Sole | 2026-08-14 | |
| 2023-09-30 | $295,729 | 182,549 | Shares | Sole | 2023-11-17 | |
| 2023-06-30 | $891,287 | 362,312 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||